Results 1 to 10 of about 7,084 (168)

UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironment [PDF]

open access: yesCell Death and Disease
Dysregulation of the C5a-C5a receptor 1 (C5aR1) signalling axis underlies inflammation and immune-driven pathology. C5aR1 was traditionally thought to be primarily expressed on the cell membrane, although recent reports indicate the importance of ...
Tatsuya Suwa   +10 more
doaj   +4 more sources

Evaluating the usefulness of C5 and C5AR1 as genetic biomarkers of IgA-mediated vasculitis [PDF]

open access: yesMolecular Medicine
Background IgA-mediated vasculitis (IgAV) is a complex inflammatory disease. Unravelling its genetic background would allow us to identify genetic biomarkers that may be used as additional tools in its daily management, helping to solve the clinical ...
Joao Carlos Batista-Liz   +23 more
doaj   +3 more sources

13-methylpalmatine alleviates myocardial ischemia/reperfusion injury by potentially targeting the C5a-C5aR1 axis to inhibit neutrophil extracellular trap formation [PDF]

open access: yesRedox Biology
The complement system activation-induced inflammation is a critical contributor to myocardial ischemia/reperfusion (I/R) injury. However, effective therapeutic targets and pharmacological interventions remain limited.
Miao Zhang   +14 more
doaj   +3 more sources

C5aR1 Inhibition Alleviates Cranial Radiation-Induced Cognitive Decline. [PDF]

open access: yesCancer Res
Cranial radiation therapy (RT) for brain cancers leads to an irreversible decline in cognitive function without an available remedy. Radiation-induced cognitive decline (RICD) is a particularly pressing problem for brain cancer survivors who live long ...
Krattli RP   +12 more
europepmc   +3 more sources

Inhibition of C5a-C5aR1 axis suppresses tumour progression by enhancing antitumour immunity and chemotherapeutic effect in pancreatic ductal adenocarcinoma. [PDF]

open access: yesBr J Cancer
Complement factors regulate tumour immunity in the tumour microenvironment (TME). We investigated the functions of complement 5a (C5a) and its receptors, C5aR1 and C5aR2, in forming the C5a-C5aR1 and C5a-C5aR2 signaling axes in the immune TME of ...
Eto R   +7 more
europepmc   +2 more sources

Regulation of phosphatase and tensin homolog by complement component 5a (C5a) and its receptor (C5aR1) in lupus nephritis: A novel therapeutic target. [PDF]

open access: yesJ Cell Commun Signal
Lupus nephritis (LN), a renal manifestation of systemic lupus erythematosus, results from immune‐mediated kidney injury. The present study investigated how complement component 5a (C5a) and its receptor (C5aR1) regulate phosphatase and tensin homolog ...
Ma Y   +6 more
europepmc   +2 more sources

Bioinformatics analysis reveals C5AR1's impact on thyroid cancer development via immune infiltration. [PDF]

open access: yesSci Rep
Thyroid cancer (THCA) remains a prevalent endocrine malignancy, with limited molecular markers for accurate diagnosis and targeted therapy. This study aimed to identify key biomarkers and therapeutic targets for THCA using integrative bioinformatics and ...
Sun Y   +9 more
europepmc   +2 more sources

The Pleiotropic Effect of Complement C5a-C5aR1 Pathway in Diseases: From Immune Regulation to Targeted Therapy. [PDF]

open access: yesInt J Mol Sci
The complement system plays a pivotal role in the body’s immune defense mechanism. Its key effector molecule C5a and its primary receptor C5aR1 exhibit complex “double-edged sword” effects in various disease processes, including infectious diseases ...
Xu B   +6 more
europepmc   +2 more sources

Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4

open access: yesCell Death and Disease
Glioblastoma (GBM) is the most common primary intracranial malignant tumor. Recent literature suggests that induction of programmed death has become a mainstream cancer treatment strategy, with ferroptosis being the most widely studied mode.
Xiangrui Meng   +9 more
doaj   +2 more sources

C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer’s disease mouse model

open access: yesNature Communications
Alzheimer’s disease (AD) is the leading cause of dementia in older adults, and the need for effective, sustainable therapeutic targets is imperative. The complement pathway has been proposed as a therapeutic target.
Nicole D. Schartz   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy